Business Description
Bio Essence Corp
NAICS : 325412
SIC : 2834
ISIN : US09090C1053
Total Employee Number:
4Description
Bio Essence Corp is an herbal health, diet, and nutrition company. The Company's mission is to provide herbal health, diet, and vitamin nutritional supplements. The primary focus of BEP was producing products for BEH and McBE, along with providing original equipment manufacturing and private label services to other companies. BEH targeted and developed traditional Chinese medicines (TCM) in the form of single herbs, granules, pills, and tablets. It also offered specially formulated dietary supplements and medical food. The Company operates in one business and industry segment: the manufacture / OEM and sale of health supplement products. The group's products are RED Yeast Rice Plus, Regenva, MediDrink, and Nufargo.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | -1.81 | |||||
Debt-to-Equity | -1.1 | |||||
Debt-to-EBITDA | 1.19 | |||||
Interest Coverage | 330.25 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | -6.71 | |||||
Beneish M-Score | 2.84 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 38.1 | |||||
3-Year Book Growth Rate | 17.5 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 64.84 | |||||
9-Day RSI | 54.97 | |||||
14-Day RSI | 48.62 | |||||
3-1 Month Momentum % | -36.88 | |||||
6-1 Month Momentum % | 395.1 | |||||
12-1 Month Momentum % | 165.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.37 | |||||
Quick Ratio | 0.37 | |||||
Cash Ratio | 0.02 | |||||
Days Sales Outstanding | 1.41 | |||||
Days Payable | 10.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | 7.62 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 72.69 | |||||
Operating Margin % | 55.6 | |||||
Net Margin % | 55.01 | |||||
EBITDA Margin % | 55.6 | |||||
FCF Margin % | 49.83 | |||||
OCF Margin % | 49.83 | |||||
ROE % | Neg. Equity | |||||
ROA % | 348.53 | |||||
ROIC % | 49.3 | |||||
3-Year ROIIC % | -58.12 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 13.52 | |||||
PE Ratio without NRI | 9.32 | |||||
Price-to-Owner-Earnings | 12.29 | |||||
PS Ratio | 4.43 | |||||
Price-to-Free-Cash-Flow | 8.19 | |||||
Price-to-Operating-Cash-Flow | 8.19 | |||||
EV-to-EBIT | 10.74 | |||||
EV-to-EBITDA | 10.74 | |||||
EV-to-Revenue | 5.97 | |||||
EV-to-FCF | 11.98 | |||||
Earnings Yield (Greenblatt) % | 9.31 | |||||
FCF Yield % | 9.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BIOE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bio Essence Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2.376 | ||
| EPS (TTM) ($) | 0.02 | ||
| Beta | 12.5354 | ||
| 3-Year Sharpe Ratio | 0.64 | ||
| 3-Year Sortino Ratio | 8.2 | ||
| Volatility % | 294.72 | ||
| 14-Day RSI | 48.62 | ||
| 14-Day ATR ($) | 0.007849 | ||
| 20-Day SMA ($) | 0.2579 | ||
| 12-1 Month Momentum % | 165.79 | ||
| 52-Week Range ($) | 0.051 - 0.517 | ||
| Shares Outstanding (Mil) | 46.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bio Essence Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bio Essence Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-30 | In 139 days | ||
| Second quarter earnings results for 2026 | 2026-08-31 | In 48 days | ||
| First quarter earnings results for 2026 | 2026-05-15 | 0.38 (-1.30%) |
Show
Entries
Bio Essence Corp Frequently Asked Questions
What is Bio Essence Corp(BIOE)'s stock price today?
The current price of BIOE is $0.27. The 52 week high of BIOE is $0.52 and 52 week low is $0.05.
When is next earnings date of Bio Essence Corp(BIOE)?
The next earnings date of Bio Essence Corp(BIOE) is 2026-08-31 Est..
Does Bio Essence Corp(BIOE) pay dividends? If so, how much?
Bio Essence Corp(BIOE) does not pay dividend.
Guru Commentaries on OTCPK:BIOE
No articles.
Press Release
Articles on Bio Essence Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers